Sight Sciences wins FDA 510(k) clearance for OMNI Ultra glaucoma system

Reuters2026/08/04 22:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sight Sciences won FDA 510(k) clearance for OMNI Ultra, a minimally invasive glaucoma surgery system for canaloplasty followed by trabeculotomy in adult POAG.
U.S. commercial launch targeted for Q4 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608041737PRIMZONEFULLFEED9803800) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sight Sciences wins FDA 510(k) clearance for OMNI Ultra glaucoma system

You may also like

Crypto prices